116 related articles for article (PubMed ID: 38272230)
1. Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway.
Tripathi AK; Desai PP; Tyagi A; Lampe JB; Srivastava Y; Donkor M; Jones HP; Dzyuba SV; Crossley E; Williams NS; Vishwanatha JK
J Biol Chem; 2024 Mar; 300(3):105680. PubMed ID: 38272230
[TBL] [Abstract][Full Text] [Related]
2. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
[TBL] [Abstract][Full Text] [Related]
3. MIEN1 promotes oral cancer progression and implicates poor overall survival.
Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
[TBL] [Abstract][Full Text] [Related]
5. MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics.
Kpetemey M; Chaudhary P; Van Treuren T; Vishwanatha JK
Oncotarget; 2016 Aug; 7(34):54913-54924. PubMed ID: 27462783
[TBL] [Abstract][Full Text] [Related]
6. Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis.
Liu Y; Wang X; Li H; Guan E; Luo K
J Environ Pathol Toxicol Oncol; 2021; 40(4):87-97. PubMed ID: 34936303
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways.
Li D; Wei Y; Wang D; Gao H; Liu K
Biochem Biophys Res Commun; 2016 Apr; 472(3):465-70. PubMed ID: 26827826
[TBL] [Abstract][Full Text] [Related]
8. Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target.
Zhao HB; Zhang XF; Wang HB; Zhang MZ
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28198505
[TBL] [Abstract][Full Text] [Related]
9. CRISPR deletion of MIEN1 in breast cancer cells.
Van Treuren T; Vishwanatha JK
PLoS One; 2018; 13(10):e0204976. PubMed ID: 30286132
[TBL] [Abstract][Full Text] [Related]
10. MiR-124-5p Inhibits the Progression of Gastric Cancer by Targeting MIEN1.
Liang F; Zhang H; Qiu Y; Xu Q; Jian K; Jiang L; Wang F; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820979199. PubMed ID: 33349155
[TBL] [Abstract][Full Text] [Related]
11. MIEN1 is tightly regulated by SINE Alu methylation in its promoter.
Rajendiran S; Gibbs LD; Van Treuren T; Klinkebiel DL; Vishwanatha JK
Oncotarget; 2016 Oct; 7(40):65307-65319. PubMed ID: 27589566
[TBL] [Abstract][Full Text] [Related]
12. The circular RNA circ_0030018/miR-136/migration and invasion enhancer 1 (MIEN1) axis promotes the progression of polycystic ovary syndrome.
Xu J; Qu Q; Liu B; Shen L
Bioengineered; 2022 Mar; 13(3):5999-6011. PubMed ID: 35184658
[TBL] [Abstract][Full Text] [Related]
13. miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.
Ren H; Qi Y; Yin X; Gao J
Onco Targets Ther; 2018; 11():67-74. PubMed ID: 29339925
[TBL] [Abstract][Full Text] [Related]
14. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
[TBL] [Abstract][Full Text] [Related]
15. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
17. HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation.
Zeng C; Guo J; Wu J; Che T; Huang X; Liu H; Lin Z
J Biol Chem; 2023 Jun; 299(6):104723. PubMed ID: 37075843
[TBL] [Abstract][Full Text] [Related]
18. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
19. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
